Anionic polymers as toxin binders and antibacterial agents

Details Anionic polymers as toxin binders and antibacterial agents Anionic polymers as toxin binders and antibacterial agents

2005-05-10

2005-05-10

Page, Thurman K. (Department: 1615)

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

C424S078010, C424S078180, C424S078310

Reexamination Certificate

active

06890523

ABSTRACT:
The present invention relates to a method of inhibiting a toxin in an animal, such as a human, by administering to the animal a therapeutically effective amount of a polymer having a plurality of pendant acid functional groups which are directly attached to the polymer backbone or attached to the polymer backbone by a spacer group. The spacer group can have a length in the range from 0 to about 20 atoms. The toxin is, typically, an exotoxin secreted by a pathogenic microorganism, such as a bacterium.

REFERENCES:
patent: 3224941 (1965-12-01), Nosh et al.
patent: 3466365 (1969-09-01), Schlesinger
patent: 3987163 (1976-10-01), Rankin
patent: 4362711 (1982-12-01), Cerami
patent: 4395392 (1983-07-01), Wolgemuth
patent: 5071759 (1991-12-01), Rothman et al.
patent: 5093130 (1992-03-01), Fujii et al.
patent: 5128323 (1992-07-01), Pranger
patent: 5149523 (1992-09-01), Lundberg et al.
patent: 5149543 (1992-09-01), Cohen et al.
patent: 5171738 (1992-12-01), Kodama et al.
patent: 5231003 (1993-07-01), Coughlin et al.
patent: 5277820 (1994-01-01), Ash
patent: 5308701 (1994-05-01), Cohen et al.
patent: 5324718 (1994-06-01), Loftsson
patent: 5435821 (1995-07-01), Duvdevani et al.
patent: 5474765 (1995-12-01), Thorpe
patent: 5484773 (1996-01-01), Heerze et al.
patent: 5601823 (1997-02-01), Williams et al.
patent: 5610023 (1997-03-01), Deutsch
patent: 5614559 (1997-03-01), Singh et al.
patent: 5618825 (1997-04-01), Baldwin et al.
patent: 5635606 (1997-06-01), Heerze et al.
patent: 5643562 (1997-07-01), Kisilevsky et al.
patent: 5677343 (1997-10-01), Singh et al.
patent: 5679775 (1997-10-01), Boos et al.
patent: 5736139 (1998-04-01), Kink et al.
patent: 5762934 (1998-06-01), Williams et al.
patent: 5773000 (1998-06-01), Bostwick et al.
patent: 5800803 (1998-09-01), Mirajkar et al.
patent: 6007803 (1999-12-01), Mandeville et al.
patent: 6034129 (2000-03-01), Mandeville, III et al.
patent: 6060235 (2000-05-01), Neenan et al.
patent: 6075050 (2000-06-01), Singh et al.
patent: 6270755 (2001-08-01), Bacon Kurtz et al.
patent: 6290946 (2001-09-01), Kurtz et al.
patent: 6290947 (2001-09-01), Fitzpatrick et al.
patent: 6395777 (2002-05-01), Mandeville, III et al.
patent: 6419914 (2002-07-01), Kurtz et al.
patent: 6593366 (2003-07-01), Mandeville, III et al.
patent: 20020034491 (2002-03-01), Fitzpatrick et al.
patent: 1114997 (1981-12-01), None
patent: 0579435 (1994-01-01), None
patent: 0671162 (1995-09-01), None
patent: 0 800 862 (1997-10-01), None
patent: 2669535 (1992-05-01), None
patent: 1466702 (1977-03-01), None
patent: 002176351 (1989-01-01), None
patent: WO 9015793 (1990-12-01), None
patent: WO 9305816 (1993-04-01), None
patent: 9314146 (1993-07-01), None
patent: WO 9812203 (1998-03-01), None
patent: 9920285 (1999-04-01), None
Higaki, M., et al., “Enhancement of Immune Response to Intranasal Influenza HA Vaccine by Microparticle Resin”,Vaccine16(7):741-745 (1998).
DeRosa, A., et al., “Effects of Sodium Polystyrene Sulfonate on Gingival Plaque: Microbiological Investigation and Clinical Follow-Up”,Microbiologica19:357-362 (1996).
Carson, D.L., et al., “Ocular Toxicity of Ciprofloxacin/PSSA Fluoroquinolone Antibacterial Solution in Pigmented Rabbits”,J. Toxicol.—Cut.&Ocular Toxicol.15(2):165-178 (1996).
Moreau, J.M., et al., “Effectiveness of Ciprofloxacin-Polystyrene Sulfonate (PSS, Ciprofloxacin and Ofloxacin In A Staphylococcus Keratitis Model” (Abstract),Current Eye Research17(8):808-812 (1998).
Engel, L.S., “The Effectiveness of Two Ciprofloxacin Formulations for Experimental Pseudomonas and Staphylococcus Keratitis”,Jpn J. Opthalmol., 40(2):212-219 (1996).
Seitlin, L., et al., “Tests of Vaginal Microbioides in the Mouse Genital Herpes Model”,Contraception, 66:329-335 (1997).
Rashid, A., et al., “Necrosis of the Gastrointestinal Tract in Uremic Patients as a Result of Sodium Polystyrene Sulfonate (Kayexalate) in Sorbitol”,American J. if Surgical Pathology, 21(1):60-69 (1997).
Gerstman, B., et al., “Intestinal Necrosis Associated with Postoperative Orally Administered Sodium Polystyrene Sulfonate in Sorbitol”,Am. J. of Kidney Diseases, 20(2):159-161 (1992).
Linakis, J.G., et al., “Multiple-Dose Sodium Polystyrene Sulfonate in Lithium Intoxication: An Animal Model”,Pharmacology&Toxicology, 70:38-40 (1992).
Mohan, P., et al., “Sulfonic Acid Polymers as a New Class of Human Immunodeficiency Virus Inhibitors”,Antiviral Research, 18:139-150 (1992).
Taylor, N.S., et al., “Binding of Clostridium Difficile Cytotoxin and Vancomycin by Anion-Exchange Resins”,J. of Infectious Diseases, 141(1):92-97 (1980).
Burbige, E.J., et al., “Pseudomembranous Colitis”,JAMA, 231(11):1157-1158 (1975).
Lipman, N.S., et al., “Utilization of Cholestyramine Resin as a Preventive Treatment for Antibiotic (Clindamycin) Induced Enterotoxaemia in the Rabbit”,Laboratory Animals, 26:1-8 (1992).
Bartlett, J.G., et al.,The Lancet, 258-259 (1978).
Tedesco, F.J., “Treatment of Recurrent Antibiotic-Associated Pseudomembranous Colitis”,Am. J. of Gastroenterology, 77(4):220-221 (1982).
Regelson, W., “The Antimitotic Activity of Polyanions,”Advances in Chemotherapy3:303-371 (1968).
Vogl, O. and Tirrell, D., “Functional Polymers with Biologically Active Groups,”J. Macromol. Sci.-Chem., A13(3), pp. 415-439 (1979).
Itoh, et al., “Suppression of Influenza Virus Infection by an N-Thicacetylneuraminic Acid Acrylamide Copolymer Resistant to Neurominidase”Virology, 212:340-347 (1995).

Affiliated with

Also associated with

Rating

Anionic polymers as toxin binders and antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anionic polymers as toxin binders and antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anionic polymers as toxin binders and antibacterial agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3407697